Genentech – The Beginnings of Biotech
★★★★★
★★★★★
Regular price
€19.99
Regular price
€21.99
Sale
Sale price
€19.99
A01=Sally Smith Hughes
Age Group_Uncategorized
Age Group_Uncategorized
ambition
Author_Sally Smith Hughes
automatic-update
biography
biotech
business
capitalism
Category1=Non-Fiction
Category=KND
Category=KNDH1
Category=PDX
commerce
commercialism
COP=United States
corporation
Delivery_Delivery within 10-20 working days
eli lilly contract
entrepreneur
eq_business-finance-law
eq_isMigrated=2
eq_non-fiction
eq_science
genentech
genetic engineering
government regulation
greed
growth hormone
healthcare
herbert boyer
human insulin project
interferon
ipo
Language_English
medicine
nonfiction
PA=Available
patents
pharmaceuticals
Price_€10 to €20
profile
profit
PS=Active
publicity
recombinant dna
robert swanson
science
scientific ethics
softlaunch
start up
success
technology
venture capital
Product details
- ISBN 9780226045511
- Weight: 390g
- Dimensions: 162 x 229mm
- Publication Date: 08 Apr 2013
- Publisher: The University of Chicago Press
- Publication City/Country: US
- Product Form: Paperback
- Language: English
Delivery/Collection within 10-20 working days
Our Delivery Time Frames Explained
2-4 Working Days: Available in-stock
10-20 Working Days: On Backorder
Will Deliver When Available: On Pre-Order or Reprinting
We ship your order once all items have arrived at our warehouse and are processed. Need those 2-4 day shipping items sooner? Just place a separate order for them!
In the fall of 1980, Genentech, Inc., a little-known California genetic engineering company, became the overnight darling of Wall Street, raising over $38 million in its initial public stock offering. Lacking marketed products or substantial profit, the firm nonetheless saw its share price escalate from $35 to $89 in the first few minutes of trading, at that point the largest gain in stock market history. Coming at a time of economic recession and declining technological competitiveness in the United States, the event provoked banner headlines and ignited a period of speculative frenzy over biotechnology as a revolutionary means for creating new and better kinds of pharmaceuticals, untold profit, and a possible solution to national economic malaise. Drawing from an unparalleled collection of interviews with early biotech players, Sally Smith Hughes offers the first book-length history of this pioneering company, depicting Genentech's improbable creation, precarious youth, and ascent to immense prosperity. Hughes provides intimate portraits of the people significant to Genentech's science and business, and in doing so sheds new light on how personality affects the growth of science.
By placing Genentech's founders, followers, opponents, victims, and beneficiaries in context, Hughes also demonstrates how science interacts with commercial and legal interests and university research, and with government regulation, venture capital, and commercial profits. "Genentech" tells the story of biotechnology as it is not often told, as a risky and improbable entrepreneurial venture that had to overcome a number of powerful forces working against it.
Sally Smith Hughes is a historian of science at the Bancroft Library at the University of California, Berkeley. She is the author of The Virus: A History of the Concept and the creator of an extensive collection of in-depth oral histories on bioscience, biomedicine, and biotechnology.
Qty: